{"id":"NCT00765076","sponsor":"GlaxoSmithKline","briefTitle":"Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older","officialTitle":"Observer-blind Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-10-16","primaryCompletion":"2009-12-04","completion":"2009-12-04","firstPosted":"2008-10-02","resultsPosted":"2012-04-05","lastUpdate":"2018-07-31"},"enrollment":192,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"GSK Biologicals' influenza vaccine GSK2186877A","otherNames":[]},{"type":"BIOLOGICAL","name":"GSK Biologicals' Fluarix","otherNames":[]}],"arms":[{"label":"New generation influenza vaccine GSK2186877A Group","type":"EXPERIMENTAL"},{"label":"Fluarix elderly Group","type":"ACTIVE_COMPARATOR"},{"label":"Fluarix young Group","type":"ACTIVE_COMPARATOR"}],"summary":"This clinical trial aims to study the immunogenicity of GSK Biologicals' influenza vaccine GSK2186877A in people aged 65 years or older.","primaryOutcome":{"measure":"The Geometric Mean (GM) Number of Influenza-specific CD4 T-cells Per Million CD4+ T-cells Identified After in Vitro Stimulation With Pooled Vaccine Strains Which Are Producing at Least Two Different Markers","timeFrame":"Day 21","effectByArm":[{"arm":"New Generation Influenza Vaccine GSK2186877A Group","deltaMin":3371.11,"sd":3602.15},{"arm":"Fluarix Elderly Group","deltaMin":2108.1,"sd":1728.38}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":4,"countries":["United States","Spain"]},"refs":{"pmids":["25078387"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":69},"commonTop":["Pain","Fatigue","Headache","Myalgia","Arthralgia"]}}